Synthesis and biological evaluation of novel quinoline analogs of ketoprofen as multidrug resistance protein ۲ (MRP۲) inhibitors

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 227

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-24-6_013

تاریخ نمایه سازی: 17 خرداد 1400

چکیده مقاله:

Objective(s): A new series of quinoline analogs of ketoprofen was designed and synthesized as multidrug resistance protein ۲ (MRP۲) inhibitors using ketoprofen as the lead compounds.Materials and Methods:  The cytotoxic activity of the compounds was evaluated againt two cancer cell lines including A۲۷۸۰/RCIS (MRP۲-overexpressing ovarian carcinoma), A۲۷۸۰, drug-sensitive ovarian carcinoma using MTT assay. Compounds showing low toxicity in MTT test were selected to investigate their MRP inhibition activity. MRP۲ inhibitory potency was evaluated by determination of the uptake amount of fluorescent ۵-carboxy fluorescein diacetate (۵-CFDA) substrate, by A۲۷۸۰/RCIS in the presence of the selected compounds. Mode of interaction between synthesized ligands and homology modeled MRP۲ was investigated by MOE software. Results: Compound ۶d, a ۴-carboxy quinoline possessing dimethoxy phenyl in position ۲ of quinoline ring, showed the most MRP۲ inhibition activity among all the quinolines and more than the reference drug ketoprofen. MRP۲ inhibition activity of compound ۷d was less in comparison to that of compound ۶d, indicating that carboxyl group in position ۴ of quinoline may interact with MRP۲.  Docking studies showed that compound ۷d methyl ester of ۶d, interacted less compared to its parent ۶d, which is consistent with biological results.Conclusion: This study indicates that ۶- or ۸-benzoyl-۲-arylquinoline is a suitable scaffold to design MRP۲ inhibitors. The position of benzoyl in quinoline ring is important in inhibition of MRP۲. Generally, MRP۲ inhibition activity of compound ۷d was less in comparison to that of ۶d, indicating that carboxyl group in position ۴ of quinoline may interact with MRP۲.

کلیدواژه ها:

نویسندگان

Fatemeh Mosafa

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Farzin Hadizadeh

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Faezeh Fathi

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Zahra Eslami Nasab

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Tahereh Pourzahed

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

Sayyed Mohammad Aboutorabzade

Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Razieh Ghodsi

Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Siegel RL, Miller KD, Jemal A. CA Cancer J Clin ...
  • Cozzi P. The discovery of a new potential anticancer drug: ...
  • Liang XJ, Chen C, Zhao Y, Wang PC. Circumventing tumor ...
  • Beretta GL, Cassinelli G, Pennati M, Zuco V, Gatti L. ...
  • Staud F, Pavek P. Breast cancer resistance protein (BCRP/ABCG۲). Int ...
  • Hosseinzadeh H, Mazaheri F, Ghodsi R. Pharmacological effects of a ...
  • Zarghi A, Arfaei S. Selective COX-۲ Inhibitors: A Review of ...
  • Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as ...
  • Perkovic I, Butula I, Kralj M, Martin-Kleiner I, Balzarini J, ...
  • Amin R, Kamitani H, Sultana H, Taniura S, Islam A, ...
  • Carrett-Dias M, Votto AP, Filgueira Dde M, Almeida DV, Vallochi ...
  • Draper MP, Martell RL, Levy SB. Indomethacin-mediated reversal of resistance ...
  • Duffy CP, Elliott CJ, O’Connor RA, Heenan MM, Coyle S, ...
  • El-Sheikh AA, van den Heuvel JJ, Koenderink JB, Russel FG. ...
  • Gruber BM, Bubko I, Krzyszton-Russjan J, Anuszewska EL. Synergistic action ...
  • Maguire AR, Plunkett SJ, Papot S, Clynes M, O’Connor R, ...
  • O’Connor R, Heenan M, Connolly L, Larkin A, Clynes M. ...
  • O’Connor R, O’Leary M, Ballot J, Collins CD, Kinsella P, ...
  • Roller A, Bahr OR, Streffer J, Winter S, Heneka M, ...
  • Rosenbaum C, Rohrs S, Muller O, Waldmann H. Modulation of ...
  • Touhey S, O’Connor R, Plunkett S, Maguire A, Clynes M. ...
  • Zhang L, Liu L, Zheng C, Wang Y, Nie X, ...
  • Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Tima S, Chanarat P, ...
  • Nakamichi N, Ishimoto T, Yamauchi Y, Masuo Y, Kato Y. ...
  • O’CONNOR R. The pharmacology of cancer resistance. Anticancer Res ۲۰۰۷;۲۷:۱۲۶۷-۱۲۷۲ ...
  • El-Sheikh AA, van den Heuvel JJ, Koenderink JB, Russel FG. ...
  • Rijpma SR, van den Heuvel JJ, van der Velden M, ...
  • Nakamura T, Oka M, Aizawa K, Soda H, Fukuda M, ...
  • Wu CP, Klokouzas A, Hladky SB, Ambudkar SV, Barrand MA. ...
  • Gekeler V, Ise W, Sanders KH, Ulrich WR, Beck J. ...
  • Karthikeyan C, Malla R, Ashby CR, Jr., Amawi H, Abbott ...
  • Behbahani FS, Tabeshpour J, Mirzaei S, Golmakaniyoon S, Tayarani-Najaran Z, ...
  • Ghodsi R, Azizi E, Ferlin MG, Pezzi V, Zarghi A. ...
  • Ghodsi R, Azizi E, Zarghi A. Design, synthesis and biological ...
  • Golmakaniyoon S, Askari VR, Abnous K, Zarghi A, Ghodsi R. ...
  • Jafari F, Baghayi H, Lavaee P, Hadizadeh F, Soltani F, ...
  • Karimikia E, Behravan J, Zarghi A, Ghandadi M, Malayeri SO, ...
  • Malayeri SO, Abnous K, Arab A, Akaberi M, Mehri S, ...
  • Malayeri SO, Tayarani-Najaran Z, Behbahani FS, Rashidi R, Delpazir S, ...
  • Mirzaei S, Eisvand F, Hadizadeh F, Mosaffa F, Ghasemi A, ...
  • Mirzaei S, Hadizadeh F, Eisvand F, Mosaffa F, Ghodsi R. ...
  • Zarghi A, Ghodsi R. Design, synthesis, and biological evaluation of ...
  • Aboutorabzadeh SM, Mosaffa F, Hadizadeh F, Ghodsi R. Design, synthesis, ...
  • Mahdizadeh S, Karimi G, Behravan J, Arabzadeh S, Lage H, ...
  • Xing L, Hu Y, Lai Y. Advancement of structure-activity relationship ...
  • Nies AT, König J, Cui Y, Brom M, Spring H, ...
  • Williamson G, Aeberli I, Miguet L, Zhang Z, Sanchez MB, ...
  • نمایش کامل مراجع